Select Publications
Journal articles
2023, 'Risk for Congenital Anomalies in Children Conceived With Medically Assisted Fertility Treatment', Annals of Internal Medicine, 176, pp. 1308 - 1320, http://dx.doi.org/10.7326/M23-0872
,2023, 'The MothersBabies Study, an Australian Prospective Cohort Study Analyzing the Microbiome in the Preconception and Perinatal Period to Determine Risk of Adverse Pregnancy, Postpartum, and Child-Related Health Outcomes: Study Protocol', International Journal of Environmental Research and Public Health, 20, pp. 6736, http://dx.doi.org/10.3390/ijerph20186736
,2023, 'Information and decision support needs: A survey of women interested in receiving planned oocyte cryopreservation information', Journal of Assisted Reproduction and Genetics, 40, pp. 1265 - 1280, http://dx.doi.org/10.1007/s10815-023-02796-x
,2023, 'Oocyte-Secreted Serum Biomarkers GDF9 and BMP15 in Women with Endometriosis', Reproductive Sciences, 30, pp. 1521 - 1527, http://dx.doi.org/10.1007/s43032-022-01107-6
,2023, 'Serum anti-Müllerian hormone (AMH) concentration during pregnancy: a longitudinal study', Reproduction and Fertility, 4, http://dx.doi.org/10.1530/RAF-22-0128
,2023, 'Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome', Clinical Endocrinology, 98, pp. 567 - 577, http://dx.doi.org/10.1111/cen.14851
,2022, 'Declining muscle NAD+ in a hyperandrogenism PCOS mouse model: Possible role in metabolic dysregulation', Molecular Metabolism, 65, http://dx.doi.org/10.1016/j.molmet.2022.101583
,2022, 'Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model', American Journal of Physiology - Endocrinology and Metabolism, 323, pp. E145 - E158, http://dx.doi.org/10.1152/ajpendo.00418.2021
,2022, 'Unique Deep Radiomic Signature Shows NMN Treatment Reverses Morphology of Oocytes from Aged Mice', Biomedicines, 10, http://dx.doi.org/10.3390/biomedicines10071544
,2022, 'Population-wide contribution of medically assisted reproductive technologies to overall births in Australia: Temporal trends and parental characteristics', Human Reproduction, 37, pp. 1047 - 1058, http://dx.doi.org/10.1093/humrep/deac032
,2022, 'Multispectral autofluorescence characteristics of reproductive aging in old and young mouse oocytes', Biogerontology, 23, pp. 237 - 249, http://dx.doi.org/10.1007/s10522-022-09957-y
,2022, 'Editorial: Clinical Applications of Anti-Mullerian Hormone and Its Measurement in Reproductive Medicine and Women’s Health', Frontiers in Endocrinology, 13, http://dx.doi.org/10.3389/fendo.2022.879053
,2022, 'Patient burden and healthcare resource utilization of regimens for ovarian stimulation', Reproductive BioMedicine Online, 44, pp. 573 - 581, http://dx.doi.org/10.1016/j.rbmo.2021.03.019
,2022, 'Four-dimensional ultrasound biometry following botulinum toxin type A injection to the pelvic floor', Neurourology and Urodynamics, 41, pp. 375 - 382, http://dx.doi.org/10.1002/nau.24833
,2022, 'Androgen Actions in Adipose Tissue, But Not Skeletal Muscle, are Involved in the Development of Metabolic PCOS Features in a Mouse Model', Fertility & Reproduction, 04, pp. 169 - 169, http://dx.doi.org/10.1142/s2661318222740814
,2022, 'Application of Ex-Vivo In Vitro Maturation (IVM) to Fertility Preservation in Cancer Patients', Fertility & Reproduction, 04, pp. 133 - 133, http://dx.doi.org/10.1142/s2661318222740450
,2022, 'Assessment of Oocyte Quality Using Deep Radiomic Signature of Oocyte Morphology in the Mouse', Fertility & Reproduction, 04, pp. 135 - 135, http://dx.doi.org/10.1142/s2661318222740474
,2022, 'Higher Doses of FSH Used for Superovulation Do Not Adversely Affect Embryonic Ploidy: A Randomised Controlled Trial (Stimulation Resulting in Embryonic Aneuploidy Using Menopur (STREAM) Trial)', Fertility & Reproduction, 04, pp. 142 - 142, http://dx.doi.org/10.1142/s2661318222740541
,2022, 'Opportunities and Challenges Arising from the Australian Male Infertility Exposure (AMIE) Study', Fertility & Reproduction, 04, pp. 174 - 174, http://dx.doi.org/10.1142/s2661318222740851
,2022, 'Prediction of Progression from Oocyte to Useable Blastocyst Using Deep Radiomic Signatures: Preliminary Results', Fertility & Reproduction, 04, pp. 136 - 136, http://dx.doi.org/10.1142/s2661318222740486
,2022, 'Serum GDF9 and BMP15 as Markers of Ovarian Function in Healthy Women and Women with Polycystic Ovary Syndrome', Fertility & Reproduction, 04, pp. 141 - 141, http://dx.doi.org/10.1142/s266131822274053x
,2021, 'Comparison of the number of oocytes obtained after ovarian stimulation between Chinese and Caucasian women undergoing in vitro fertilization using a standardized stimulation regime', Journal of Ovarian Research, 14, http://dx.doi.org/10.1186/s13048-021-00928-4
,2021, 'Translational Physiology of Anti-Müllerian Hormone: Clinical Applications in Female Fertility Preservation and Cancer Treatment', Frontiers in Endocrinology, 12, pp. 689532, http://dx.doi.org/10.3389/fendo.2021.689532
,2021, 'Exploratory analysis of serum concentrations of oocyte biomarkers growth differentiation factor 9 and bone morphogenetic protein 15 in ovulatory women across the menstrual cycle', Fertility and Sterility, 116, pp. 546 - 557, http://dx.doi.org/10.1016/j.fertnstert.2021.02.001
,2021, 'Pathogenesis of reproductive and metabolic PCOSTraits in a mouse model', Journal of the Endocrine Society, 5, http://dx.doi.org/10.1210/jendso/bvab060
,2021, 'Challenges in Measuring AMH in the Clinical Setting', Frontiers in Endocrinology, 12, http://dx.doi.org/10.3389/fendo.2021.691432
,2021, 'Serum Concentrations of GDF9 and BMP15 Across the Menstrual Cycle', Journal of the Endocrine Society, 5, pp. A734 - A735, http://dx.doi.org/10.1210/jendso/bvab048.1494
,2021, 'A bespoke data linkage of an IVF clinical quality registry to population health datasets; methods and performance', International Journal of Population Data Science, 6, pp. 1679, http://dx.doi.org/10.23889/ijpds.v6i1.1679
,2021, 'Higher Doses of FSH Used for Superovulation Do Not Adversely Affect Embryonic Ploidy: A Randomized Controlled Trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM) Trial)', Fertility & Reproduction, 03, pp. 108 - 114, http://dx.doi.org/10.1142/s2661318221500146
,2020, 'Defining the impact of dietary macronutrient balance on PCOS traits', Nature Communications, 11, http://dx.doi.org/10.1038/s41467-020-19003-5
,2020, 'Should couples with unexplained infertility have three to six cycles of intrauterine insemination with ovarian stimulation or in vitro fertilization as first-line treatment?', Fertility and Sterility, 114, pp. 1141 - 1148, http://dx.doi.org/10.1016/j.fertnstert.2020.10.029
,2020, 'Funding and public reporting strategies for reducing multiple pregnancy from fertility treatments', Fertility and Sterility, 114, pp. 715 - 721, http://dx.doi.org/10.1016/j.fertnstert.2020.08.1405
,2020, 'Immunocytochemical Localization of Olfactory-signaling Molecules in Human and Rat Spermatozoa', Journal of Histochemistry and Cytochemistry, 68, pp. 491 - 513, http://dx.doi.org/10.1369/0022155420939833
,2020, 'Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model', Journal of Endocrinology, 245, pp. 381 - 395, http://dx.doi.org/10.1530/JOE-19-0530
,2020, 'MON-022 Dissecting the Interplay Between Diet and PCOS Pathology on Gut Microbiota in a PCOS Mouse Model', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa046.568
,2020, 'SAT-018 Androgen Actions in Adipose Tissue and the Brain Are Key Mediators in the Development of Polycystic Ovary Syndrome', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa046.088
,2020, 'A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain', Reproductive Biology and Endocrinology, 18, http://dx.doi.org/10.1186/s12958-020-00586-z
,2020, 'Supportive oncofertility care, psychological health and reproductive concerns: a qualitative study', Supportive Care in Cancer, 28, pp. 809 - 817, http://dx.doi.org/10.1007/s00520-019-04883-1
,2020, 'Projecting future utilization of medically assisted fertility treatments', Population Studies, 74, pp. 23 - 38, http://dx.doi.org/10.1080/00324728.2019.1676461
,2020, 'Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model', Endocrinology (United States), 161, pp. 1 - 15, http://dx.doi.org/10.1210/ENDOCR/BQAA061
,2020, 'Clinical summary guide: Reproduction in women with previous abdominopelvic radiotherapy or total body irradiation', Human Reproduction Open, 2020, http://dx.doi.org/10.1093/hropen/hoaa045
,2020, 'Creating a global community of practice for oncofertility', Journal of Global Oncology, 6, pp. 317 - 330, http://dx.doi.org/10.1200/JGO.2015.000307
,2020, 'Creating a Global Community of Practice for Oncofertility.', JCO Glob Oncol, 6, pp. 317 - 330, http://dx.doi.org/10.1200/GO.22.00007
,2019, 'Preimplantation genetic screening should be used in all in vitro fertilisation cycles in women over the age of 35 years: AGAINST: Pre-implantation genetic screening should not be used in all IVF cycles in women over the age of 35 years', BJOG: An International Journal of Obstetrics and Gynaecology, 126, pp. 1555, http://dx.doi.org/10.1111/1471-0528.15942
,2019, 'The Development of an International Oncofertility Competency Framework: A Model to Increase Oncofertility Implementation', Oncologist, 24, pp. e1450 - e1459, http://dx.doi.org/10.1634/theoncologist.2019-0043
,2019, 'Infertility management in women and men attending primary care - Patient characteristics, management actions and referrals', Human Reproduction, 34, pp. 2173 - 2183, http://dx.doi.org/10.1093/humrep/dez172
,2019, 'A Review of First Line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome', Medical sciences (Basel, Switzerland), 7, http://dx.doi.org/10.3390/medsci7090095
,2019, 'Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review', Reproductive BioMedicine Online, 39, pp. 467 - 476, http://dx.doi.org/10.1016/j.rbmo.2019.04.019
,2019, 'Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 during IVF and in Women with Reproductive Pathologies', Endocrinology, 160, pp. 2298 - 2313, http://dx.doi.org/10.1210/en.2019-00264
,2019, 'A Review of Second- and Third-line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome', Medical sciences (Basel, Switzerland), 7, http://dx.doi.org/10.3390/medsci7070075
,